Failure of intravitreal bevacizumab in the treatment of choroidal metastasis.

BackgroundMetastasis to choroid is the most common intraocular malignancy, arising most frequently from carcinoma of breast in women and lung in men. Recent case reports have described successful use of intravitreal bevacizumab to achieve local control of such tumours.Materials and methodsFive cases of choroidal metastases from varying primaries: breast, lung, and colon were treated with intravitreal bevacizumab, and tumour response observed and documented with serial photographs and B-scans.ResultsFour of the five tumours were seen to progress despite intravitreal bevacizumab treatment.ConclusionsIntravitreal bevacizumab as the primary treatment of choroidal metastases is not recommended and should not delay more effective alternative treatments. [ABSTRACT FROM AUTHOR]